1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Platinum-based Anticancer Drugs Consumption 2016-2026

2.1.2 Platinum-based Anticancer Drugs Consumption CAGR by Region

2.2 Platinum-based Anticancer Drugs Segment by Type

2.2.1 Cisplatin

2.2.2 Carboplatin

2.2.3 Oxaliplatin

2.2.4 Nedaplatin

2.2.5 Others

2.3 Platinum-based Anticancer Drugs Sales by Type

2.3.1 Global Platinum-based Anticancer Drugs Sales Market Share by Type (2016-2021)

2.3.2 Global Platinum-based Anticancer Drugs Revenue and Market Share by Type (2016-2021)

2.3.3 Global Platinum-based Anticancer Drugs Sale Price by Type (2016-2021)

2.4 Platinum-based Anticancer Drugs Segment by Application

2.4.1 Testicular Cancer

2.4.2 Osteosarcoma

2.4.3 Breast Cancer

2.4.4 Esophageal Cancer

2.4.5 NSCLC

2.4.6 Other

2.5 Platinum-based Anticancer Drugs Sales by Application

2.5.1 Global Platinum-based Anticancer Drugs Sale Market Share by Application (2016-2021)

2.5.2 Global Platinum-based Anticancer Drugs Revenue and Market Share by Application (2016-2021)

2.5.3 Global Platinum-based Anticancer Drugs Sale Price by Application (2016-2021)

3 Global Platinum-based Anticancer Drugs by Company

3.1 Global Platinum-based Anticancer Drugs Sales Market Share by Company

3.1.1 Global Platinum-based Anticancer Drugs Sales by Company (2019-2021)

3.1.2 Global Platinum-based Anticancer Drugs Sales Market Share by Company (2019-2021)

3.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Company

3.2.1 Global Platinum-based Anticancer Drugs Revenue by Company (2019-2021)

3.2.2 Global Platinum-based Anticancer Drugs Revenue Market Share by Company (2019-2021)

3.3 Global Platinum-based Anticancer Drugs Sale Price by Company

3.4 Global Manufacturers Platinum-based Anticancer Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Platinum-based Anticancer Drugs Product Location Distribution

3.4.2 Players Platinum-based Anticancer Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Platinum-based Anticancer Drugs by Region

4.1 Global Platinum-based Anticancer Drugs by Region

4.1.1 Global Platinum-based Anticancer Drugs Sales by Region

4.1.2 Global Platinum-based Anticancer Drugs Revenue by Region

4.2 Americas Platinum-based Anticancer Drugs Sales Growth

4.3 APAC Platinum-based Anticancer Drugs Sales Growth

4.4 Europe Platinum-based Anticancer Drugs Sales Growth

4.5 Middle East & Africa Platinum-based Anticancer Drugs Sales Growth

5 Americas

5.1 Americas Platinum-based Anticancer Drugs Sales by Country

5.1.1 Americas Platinum-based Anticancer Drugs Sales by Country (2016-2021)

5.1.2 Americas Platinum-based Anticancer Drugs Revenue by Country (2016-2021)

5.2 Americas Platinum-based Anticancer Drugs Sales by Type

5.3 Americas Platinum-based Anticancer Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Platinum-based Anticancer Drugs Sales by Region

6.1.1 APAC Platinum-based Anticancer Drugs Sales by Region (2016-2021)

6.1.2 APAC Platinum-based Anticancer Drugs Revenue by Region (2016-2021)

6.2 APAC Platinum-based Anticancer Drugs Sales by Type

6.3 APAC Platinum-based Anticancer Drugs Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Platinum-based Anticancer Drugs by Country

7.1.1 Europe Platinum-based Anticancer Drugs Sales by Country (2016-2021)

7.1.2 Europe Platinum-based Anticancer Drugs Revenue by Country (2016-2021)

7.2 Europe Platinum-based Anticancer Drugs Sales by Type

7.3 Europe Platinum-based Anticancer Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Platinum-based Anticancer Drugs by Country

8.1.1 Middle East & Africa Platinum-based Anticancer Drugs Sales by Country (2016-2021)

8.1.2 Middle East & Africa Platinum-based Anticancer Drugs Revenue by Country (2016-2021)

8.2 Middle East & Africa Platinum-based Anticancer Drugs Sales by Type

8.3 Middle East & Africa Platinum-based Anticancer Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Platinum-based Anticancer Drugs Distributors

10.3 Platinum-based Anticancer Drugs Customer

11 Global Platinum-based Anticancer Drugs Market Forecast

11.1 Global Platinum-based Anticancer Drugs Forecast by Region

11.1.1 Global Platinum-based Anticancer Drugs Forecast by Regions (2021-2026)

11.2.2 Global Platinum-based Anticancer Drugs Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Country

11.3 APAC Forecast by Region

11.4 Europe Forecast by Country

11.5 Middle East & Africa Forecast by Country

11.6 Global Platinum-based Anticancer Drugs Forecast by Type

11.7 Global Platinum-based Anticancer Drugs Forecast by Application

12 Key Players Analysis

12.1 Sanofi-Aventis

12.1.1 Sanofi-Aventis Company Information

12.1.2 Sanofi-Aventis Platinum-based Anticancer Drugs Product Offered

12.1.3 Sanofi-Aventis Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Sanofi-Aventis Main Business Overview

12.1.5 Sanofi-Aventis Latest Developments

12.2 Yakult honsha

12.2.1 Yakult honsha Company Information

12.2.2 Yakult honsha Platinum-based Anticancer Drugs Product Offered

12.2.3 Yakult honsha Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Yakult honsha Main Business Overview

12.2.5 Yakult honsha Latest Developments

12.3 Dr Reddy's laboratories

12.3.1 Dr Reddy's laboratories Company Information

12.3.2 Dr Reddy's laboratories Platinum-based Anticancer Drugs Product Offered

12.3.3 Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Dr Reddy's laboratories Main Business Overview

12.3.5 Dr Reddy's laboratories Latest Developments

12.4 Sun Pharmaceutical

12.4.1 Sun Pharmaceutical Company Information

12.4.2 Sun Pharmaceutical Platinum-based Anticancer Drugs Product Offered

12.4.3 Sun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Sun Pharmaceutical Main Business Overview

12.4.5 Sun Pharmaceutical Latest Developments

12.5 Teva

12.5.1 Teva Company Information

12.5.2 Teva Platinum-based Anticancer Drugs Product Offered

12.5.3 Teva Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Teva Main Business Overview

12.5.5 Teva Latest Developments

12.6 Fresenius Kabi

12.6.1 Fresenius Kabi Company Information

12.6.2 Fresenius Kabi Platinum-based Anticancer Drugs Product Offered

12.6.3 Fresenius Kabi Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Fresenius Kabi Main Business Overview

12.6.5 Fresenius Kabi Latest Developments

12.7 Hospira(Pfizer)

12.7.1 Hospira(Pfizer) Company Information

12.7.2 Hospira(Pfizer) Platinum-based Anticancer Drugs Product Offered

12.7.3 Hospira(Pfizer) Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 Hospira(Pfizer) Main Business Overview

12.7.5 Hospira(Pfizer) Latest Developments

12.8 Mylan

12.8.1 Mylan Company Information

12.8.2 Mylan Platinum-based Anticancer Drugs Product Offered

12.8.3 Mylan Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Mylan Main Business Overview

12.8.5 Mylan Latest Developments

12.9 Taj Pharmaceuticals

12.9.1 Taj Pharmaceuticals Company Information

12.9.2 Taj Pharmaceuticals Platinum-based Anticancer Drugs Product Offered

12.9.3 Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Taj Pharmaceuticals Main Business Overview

12.9.5 Taj Pharmaceuticals Latest Developments

12.10 Jiangsu Hengrui Medicine

12.10.1 Jiangsu Hengrui Medicine Company Information

12.10.2 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product Offered

12.10.3 Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Jiangsu Hengrui Medicine Main Business Overview

12.10.5 Jiangsu Hengrui Medicine Latest Developments

12.11 Nanjing Pharmaceutical Factory

12.11.1 Nanjing Pharmaceutical Factory Company Information

12.11.2 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product Offered

12.11.3 Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Nanjing Pharmaceutical Factory Main Business Overview

12.11.5 Nanjing Pharmaceutical Factory Latest Developments

12.12 Jiangsu Aosaikang Pharmaceutical

12.12.1 Jiangsu Aosaikang Pharmaceutical Company Information

12.12.2 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product Offered

12.12.3 Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Jiangsu Aosaikang Pharmaceutical Main Business Overview

12.12.5 Jiangsu Aosaikang Pharmaceutical Latest Developments

12.13 Qilu Pharmaceutical

12.13.1 Qilu Pharmaceutical Company Information

12.13.2 Qilu Pharmaceutical Platinum-based Anticancer Drugs Product Offered

12.13.3 Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Qilu Pharmaceutical Main Business Overview

12.13.5 Qilu Pharmaceutical Latest Developments

12.14 Hisun Pharmaceutical

12.14.1 Hisun Pharmaceutical Company Information

12.14.2 Hisun Pharmaceutical Platinum-based Anticancer Drugs Product Offered

12.14.3 Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Hisun Pharmaceutical Main Business Overview

12.14.5 Hisun Pharmaceutical Latest Developments

12.15 Luoxin

12.15.1 Luoxin Company Information

12.15.2 Luoxin Platinum-based Anticancer Drugs Product Offered

12.15.3 Luoxin Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.15.4 Luoxin Main Business Overview

12.15.5 Luoxin Latest Developments

12.16 Lingnan Pharmacy

12.16.1 Lingnan Pharmacy Company Information

12.16.2 Lingnan Pharmacy Platinum-based Anticancer Drugs Product Offered

12.16.3 Lingnan Pharmacy Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.16.4 Lingnan Pharmacy Main Business Overview

12.16.5 Lingnan Pharmacy Latest Developments

12.17 Hansoh Pharma

12.17.1 Hansoh Pharma Company Information

12.17.2 Hansoh Pharma Platinum-based Anticancer Drugs Product Offered

12.17.3 Hansoh Pharma Platinum-based Anticancer Drugs Sales, Revenue, Price and Gross Margin (2019-2021)

12.17.4 Hansoh Pharma Main Business Overview

12.17.5 Hansoh Pharma Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Platinum-based Anticancer Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Cisplatin

Table 3. Major Players of Carboplatin

Table 4. Major Players of Oxaliplatin

Table 5. Major Players of Nedaplatin

Table 6. Major Players of Others

Table 7. Global Platinum-based Anticancer Drugs Sales by Type (2016-2021) & (K Units)

Table 8. Global Platinum-based Anticancer Drugs Sales Market Share by Type (2016-2021)

Table 9. Global Platinum-based Anticancer Drugs Revenue by Type (2016-2021) & ($ million)

Table 10. Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2016-2021)

Table 11. Global Platinum-based Anticancer Drugs Sale Price by Type (2016-2021)

Table 12. Global Platinum-based Anticancer Drugs Sales by Application (2016-2021) & (K Units)

Table 13. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2016-2021)

Table 14. Global Platinum-based Anticancer Drugs Value by Application (2016-2021)

Table 15. Global Platinum-based Anticancer Drugs Revenue Market Share by Application (2016-2021)

Table 16. Global Platinum-based Anticancer Drugs Sale Price by Application (2016-2021)

Table 17. Global Platinum-based Anticancer Drugs Sales by Company (2019-2021) & (K Units)

Table 18. Global Platinum-based Anticancer Drugs Sales Market Share by Company (2019-2021)

Table 19. Global Platinum-based Anticancer Drugs Revenue by Company (2019-2021) ($ Millions)

Table 20. Global Platinum-based Anticancer Drugs Revenue Market Share by Company (2019-2021)

Table 21. Global Platinum-based Anticancer Drugs Sale Price by Company (2019-2021)

Table 22. Key Manufacturers Platinum-based Anticancer Drugs Producing Area Distribution and Sales Area

Table 23. Players Platinum-based Anticancer Drugs Products Offered

Table 24. Platinum-based Anticancer Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Platinum-based Anticancer Drugs Sales by Region (2016-2021) (K Units)

Table 28. Global Platinum-based Anticancer Drugs Sales Market Share by Region (2016-2021)

Table 29. Global Platinum-based Anticancer Drugs Revenue by Region (2016-2021) & ($ Millions)

Table 30. Global Platinum-based Anticancer Drugs Revenue Market Share by Region (2016-2021)

Table 31. Americas Platinum-based Anticancer Drugs Sales by Country (2016-2021) & (K Units)

Table 32. Americas Platinum-based Anticancer Drugs Sales Market Share by Country (2016-2021)

Table 33. Americas Platinum-based Anticancer Drugs Revenue by Country (2016-2021) & ($ Millions)

Table 34. Americas Platinum-based Anticancer Drugs Revenue Market Share by Country (2016-2021)

Table 35. Americas Platinum-based Anticancer Drugs Sales by Type (2016-2021) & (K Units)

Table 36. Americas Platinum-based Anticancer Drugs Sales Market Share by Type (2016-2021)

Table 37. Americas Platinum-based Anticancer Drugs Sales by Application (2016-2021) & (K Units)

Table 38. Americas Platinum-based Anticancer Drugs Sales Market Share by Application (2016-2021)

Table 39. APAC Platinum-based Anticancer Drugs Sales by Region (2016-2021) & (K Units)

Table 40. APAC Platinum-based Anticancer Drugs Sales Market Share by Region (2016-2021)

Table 41. APAC Platinum-based Anticancer Drugs Revenue by Region (2016-2021) & ($ Millions)

Table 42. APAC Platinum-based Anticancer Drugs Revenue Market Share by Region (2016-2021)

Table 43. APAC Platinum-based Anticancer Drugs Sales by Type (2016-2021) & (K Units)

Table 44. APAC Platinum-based Anticancer Drugs Sales Market Share by Type (2016-2021)

Table 45. APAC Platinum-based Anticancer Drugs Sales by Application (2016-2021) & (K Units)

Table 46. APAC Platinum-based Anticancer Drugs Sales Market Share by Application (2016-2021)

Table 47. Europe Platinum-based Anticancer Drugs Sales by Country (2016-2021) & (K Units)

Table 48. Europe Platinum-based Anticancer Drugs Sales Market Share by Country (2016-2021)

Table 49. Europe Platinum-based Anticancer Drugs Revenue by Country (2016-2021) & ($ Millions)

Table 50. Europe Platinum-based Anticancer Drugs Revenue Market Share by Country (2016-2021)

Table 51. Europe Platinum-based Anticancer Drugs Sales by Type (2016-2021) & (K Units)

Table 52. Europe Platinum-based Anticancer Drugs Sales Market Share by Type (2016-2021)

Table 53. Europe Platinum-based Anticancer Drugs Sales by Application (2016-2021) & (K Units)

Table 54. Europe Platinum-based Anticancer Drugs Sales Market Share by Application (2016-2021)

Table 55. Middle East & Africa Platinum-based Anticancer Drugs Sales by Country (2016-2021) & (K Units)

Table 56. Middle East & Africa Platinum-based Anticancer Drugs Sales Market Share by Country (2016-2021)

Table 57. Middle East & Africa Platinum-based Anticancer Drugs Revenue by Country (2016-2021) & ($ Millions)

Table 58. Middle East & Africa Platinum-based Anticancer Drugs Revenue Market Share by Country (2016-2021)

Table 59. Middle East & Africa Platinum-based Anticancer Drugs Sales by Type (2016-2021) & (K Units)

Table 60. Middle East & Africa Platinum-based Anticancer Drugs Sales Market Share by Type (2016-2021)

Table 61. Middle East & Africa Platinum-based Anticancer Drugs Sales by Application (2016-2021) & (K Units)

Table 62. Middle East & Africa Platinum-based Anticancer Drugs Sales Market Share by Application (2016-2021)

Table 63. Key and Potential Regions of Platinum-based Anticancer Drugs

Table 64. Key Application and Potential Industries of Platinum-based Anticancer Drugs

Table 65. Key Challenges of Platinum-based Anticancer Drugs

Table 66. Key Trends of Platinum-based Anticancer Drugs

Table 67. Platinum-based Anticancer Drugs Distributors List

Table 68. Platinum-based Anticancer Drugs Customer List

Table 69. Global Platinum-based Anticancer Drugs Sales Forecast by Region (2021-2026) & (K Units)

Table 70. Global Platinum-based Anticancer Drugs Consumption Market Forecast by Region

Table 71. Global Platinum-based Anticancer Drugs Revenue Forecast by Region (2021-2026) & ($ millions)

Table 72. Global Platinum-based Anticancer Drugs Revenue Market Share Forecast by Region (2021-2026)

Table 73. Americas Platinum-based Anticancer Drugs Sales Forecast by Country (2021-2026) & (K Units)

Table 74. Americas Platinum-based Anticancer Drugs Revenue Forecast by Country (2021-2026) & ($ millions)

Table 75. APAC Platinum-based Anticancer Drugs Sales Forecast by Region (2021-2026) & (K Units)

Table 76. APAC Platinum-based Anticancer Drugs Revenue Forecast by Region (2021-2026) & ($ millions)

Table 77. Europe Platinum-based Anticancer Drugs Sales Forecast by Country (2021-2026) & (K Units)

Table 78. Europe Platinum-based Anticancer Drugs Revenue Forecast by Country (2021-2026) & ($ millions)

Table 79. Middle East & Africa Platinum-based Anticancer Drugs Sales Forecast by Country (2021-2026) & (K Units)

Table 80. Middle East & Africa Platinum-based Anticancer Drugs Revenue Forecast by Country (2021-2026) & ($ millions)

Table 81. Global Platinum-based Anticancer Drugs Sales Forecast by Type (2021-2026) & (K Units)

Table 82. Global Platinum-based Anticancer Drugs Sales Market Share Forecast by Type (2021-2026)

Table 83. Global Platinum-based Anticancer Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 84. Global Platinum-based Anticancer Drugs Revenue Market Share Forecast by Type (2021-2026)

Table 85. Global Platinum-based Anticancer Drugs Sales Forecast by Application (2021-2026) & (K Units)

Table 86. Global Platinum-based Anticancer Drugs Sales Market Share Forecast by Application (2021-2026)

Table 87. Global Platinum-based Anticancer Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 88. Global Platinum-based Anticancer Drugs Revenue Market Share Forecast by Application (2021-2026)

Table 89. Sanofi-Aventis Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 90. Sanofi-Aventis Platinum-based Anticancer Drugs Product Offered

Table 91. Sanofi-Aventis Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 92. Sanofi-Aventis Main Business

Table 93. Sanofi-Aventis Latest Developments

Table 94. Yakult honsha Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 95. Yakult honsha Platinum-based Anticancer Drugs Product Offered

Table 96. Yakult honsha Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 97. Yakult honsha Main Business

Table 98. Yakult honsha Latest Developments

Table 99. Dr Reddy's laboratories Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 100. Dr Reddy's laboratories Platinum-based Anticancer Drugs Product Offered

Table 101. Dr Reddy's laboratories Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 102. Dr Reddy's laboratories Main Business

Table 103. Dr Reddy's laboratories Latest Developments

Table 104. Sun Pharmaceutical Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 105. Sun Pharmaceutical Platinum-based Anticancer Drugs Product Offered

Table 106. Sun Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 107. Sun Pharmaceutical Main Business

Table 108. Sun Pharmaceutical Latest Developments

Table 109. Teva Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 110. Teva Platinum-based Anticancer Drugs Product Offered

Table 111. Teva Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 112. Teva Main Business

Table 113. Teva Latest Developments

Table 114. Fresenius Kabi Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 115. Fresenius Kabi Platinum-based Anticancer Drugs Product Offered

Table 116. Fresenius Kabi Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 117. Fresenius Kabi Main Business

Table 118. Fresenius Kabi Latest Developments

Table 119. Hospira(Pfizer) Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 120. Hospira(Pfizer) Platinum-based Anticancer Drugs Product Offered

Table 121. Hospira(Pfizer) Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 122. Hospira(Pfizer) Main Business

Table 123. Hospira(Pfizer) Latest Developments

Table 124. Mylan Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 125. Mylan Platinum-based Anticancer Drugs Product Offered

Table 126. Mylan Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 127. Mylan Main Business

Table 128. Mylan Latest Developments

Table 129. Taj Pharmaceuticals Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 130. Taj Pharmaceuticals Platinum-based Anticancer Drugs Product Offered

Table 131. Taj Pharmaceuticals Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 132. Taj Pharmaceuticals Main Business

Table 133. Taj Pharmaceuticals Latest Developments

Table 134. Jiangsu Hengrui Medicine Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 135. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Product Offered

Table 136. Jiangsu Hengrui Medicine Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 137. Jiangsu Hengrui Medicine Main Business

Table 138. Jiangsu Hengrui Medicine Latest Developments

Table 139. Nanjing Pharmaceutical Factory Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 140. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Product Offered

Table 141. Nanjing Pharmaceutical Factory Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 142. Nanjing Pharmaceutical Factory Main Business

Table 143. Nanjing Pharmaceutical Factory Latest Developments

Table 144. Jiangsu Aosaikang Pharmaceutical Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 145. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Product Offered

Table 146. Jiangsu Aosaikang Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 147. Jiangsu Aosaikang Pharmaceutical Main Business

Table 148. Jiangsu Aosaikang Pharmaceutical Latest Developments

Table 149. Qilu Pharmaceutical Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 150. Qilu Pharmaceutical Platinum-based Anticancer Drugs Product Offered

Table 151. Qilu Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 152. Qilu Pharmaceutical Main Business

Table 153. Qilu Pharmaceutical Latest Developments

Table 154. Hisun Pharmaceutical Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 155. Hisun Pharmaceutical Platinum-based Anticancer Drugs Product Offered

Table 156. Hisun Pharmaceutical Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 157. Hisun Pharmaceutical Main Business

Table 158. Hisun Pharmaceutical Latest Developments

Table 159. Luoxin Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 160. Luoxin Platinum-based Anticancer Drugs Product Offered

Table 161. Luoxin Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 162. Luoxin Main Business

Table 163. Luoxin Latest Developments

Table 164. Lingnan Pharmacy Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 165. Lingnan Pharmacy Platinum-based Anticancer Drugs Product Offered

Table 166. Lingnan Pharmacy Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 167. Lingnan Pharmacy Main Business

Table 168. Lingnan Pharmacy Latest Developments

Table 169. Hansoh Pharma Basic Information, Platinum-based Anticancer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 170. Hansoh Pharma Platinum-based Anticancer Drugs Product Offered

Table 171. Hansoh Pharma Platinum-based Anticancer Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)

Table 172. Hansoh Pharma Main Business

Table 173. Hansoh Pharma Latest Developments

List of Figures

Figure 1. Picture of Platinum-based Anticancer Drugs

Figure 2. Platinum-based Anticancer Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Platinum-based Anticancer Drugs Sales Growth Rate 2016-2026 (K Units)

Figure 7. Global Platinum-based Anticancer Drugs Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Platinum-based Anticancer Drugs Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Cisplatin

Figure 10. Product Picture of Carboplatin

Figure 11. Product Picture of Oxaliplatin

Figure 12. Product Picture of Nedaplatin

Figure 13. Product Picture of Others

Figure 14. Global Platinum-based Anticancer Drugs Sales Market Share by Type in 2020

Figure 15. Global Platinum-based Anticancer Drugs Revenue Market Share by Type (2016-2021)

Figure 16. Platinum-based Anticancer Drugs Consumed in Testicular Cancer

Figure 17. Global Platinum-based Anticancer Drugs Market: Testicular Cancer (2016-2021) & (K Units)

Figure 18. Platinum-based Anticancer Drugs Consumed in Osteosarcoma

Figure 19. Global Platinum-based Anticancer Drugs Market: Osteosarcoma (2016-2021) & (K Units)

Figure 20. Platinum-based Anticancer Drugs Consumed in Breast Cancer

Figure 21. Global Platinum-based Anticancer Drugs Market: Breast Cancer (2016-2021) & (K Units)

Figure 22. Platinum-based Anticancer Drugs Consumed in Esophageal Cancer

Figure 23. Global Platinum-based Anticancer Drugs Market: Esophageal Cancer (2016-2021) & (K Units)

Figure 24. Platinum-based Anticancer Drugs Consumed in NSCLC

Figure 25. Global Platinum-based Anticancer Drugs Market: NSCLC (2016-2021) & (K Units)

Figure 26. Platinum-based Anticancer Drugs Consumed in Other

Figure 27. Global Platinum-based Anticancer Drugs Market: Other (2016-2021) & (K Units)

Figure 28. Global Platinum-based Anticancer Drugs Sales Market Share by Application (2016-2021)

Figure 29. Global Platinum-based Anticancer Drugs Revenue Market Share by Application in 2020

Figure 30. Platinum-based Anticancer Drugs Revenue Market by Company in 2020 ($ Million)

Figure 31. Global Platinum-based Anticancer Drugs Revenue Market Share by Company in 2020

Figure 32. Global Platinum-based Anticancer Drugs Sales Market Share by Regions (2016-2021)

Figure 33. Global Platinum-based Anticancer Drugs Revenue Market Share by Region in 2020

Figure 34. Americas Platinum-based Anticancer Drugs Sales 2016-2021 (K Units)

Figure 35. Americas Platinum-based Anticancer Drugs Revenue 2016-2021 ($ Millions)

Figure 36. APAC Platinum-based Anticancer Drugs Sales 2016-2021 (K Units)

Figure 37. APAC Platinum-based Anticancer Drugs Revenue 2016-2021 ($ Millions)

Figure 38. Europe Platinum-based Anticancer Drugs Sales 2016-2021 (K Units)

Figure 39. Europe Platinum-based Anticancer Drugs Revenue 2016-2021 ($ Millions)

Figure 40. Middle East & Africa Platinum-based Anticancer Drugs Sales 2016-2021 (K Units)

Figure 41. Middle East & Africa Platinum-based Anticancer Drugs Revenue 2016-2021 ($ Millions)

Figure 42. Americas Platinum-based Anticancer Drugs Sales Market Share by Country in 2020

Figure 43. Americas Platinum-based Anticancer Drugs Revenue Market Share by Country in 2020

Figure 44. Americas Platinum-based Anticancer Drugs Sales Market Share by Type in 2020

Figure 45. Americas Platinum-based Anticancer Drugs Sales Market Share by Application in 2020

Figure 46. United States Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 47. Canada Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 48. Mexico Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 49. Brazil Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 50. APAC Platinum-based Anticancer Drugs Sales Market Share by Region in 2020

Figure 51. APAC Platinum-based Anticancer Drugs Revenue Market Share by Regions in 2020

Figure 52. APAC Platinum-based Anticancer Drugs Sales Market Share by Type in 2020

Figure 53. APAC Platinum-based Anticancer Drugs Sales Market Share by Application in 2020

Figure 54. China Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 55. Japan Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 56. Korea Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 57. Southeast Asia Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 58. India Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 59. Australia Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 60. Europe Platinum-based Anticancer Drugs Sales Market Share by Country in 2020

Figure 61. Europe Platinum-based Anticancer Drugs Revenue Market Share by Country in 2020

Figure 62. Europe Platinum-based Anticancer Drugs Sales Market Share by Type in 2020

Figure 63. Europe Platinum-based Anticancer Drugs Sales Market Share by Application in 2020

Figure 64. Germany Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 65. France Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 66. UK Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 67. Italy Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 68. Russia Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 69. Middle East & Africa Platinum-based Anticancer Drugs Sales Market Share by Country in 2020

Figure 70. Middle East & Africa Platinum-based Anticancer Drugs Revenue Market Share by Country in 2020

Figure 71. Middle East & Africa Platinum-based Anticancer Drugs Sales Market Share by Type in 2020

Figure 72. Middle East & Africa Platinum-based Anticancer Drugs Sales Market Share by Application in 2020

Figure 73. Egypt Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 74. South Africa Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 75. Israel Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 76. Turkey Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 77. GCC Country Platinum-based Anticancer Drugs Revenue Growth 2016-2021 ($ Millions)

Figure 78. Channels of Distribution

Figure 79. Distributors Profiles